Home

A 19-year-old Pennsylvania man riding his bicycle across the country to raise awareness and money for breast cancer research was struck and killed by an SUV in New Mexico. Officials say John Anczarski, of Ringtown, Pa., died Tuesday of injuries suffered a day earlier in ...

NEW YORK (Reuters Health) - Lack of solid evidence doesn't seem to hamper doctors' use of new technology, as long as they can get reimbursed for it, researchers said on Monday. They found that after the U.S. Congress had mandated Medicare coverage of a digital tool to help detect breast cancer, health providers were quick to pick it up ...

Britain's health watchdog on Thursday recommended against buying a breast cancer drug for patients with advanced disease. In a statement, the National Institute for Health and Clinical Excellence said that lapatinib, sold as Tyverb by GlaxoSmithKline PLC, is not cost-effective. The drug costs about 1,600 ...

CHICAGO (Reuters) - Working with a psychologist to reduce stress can help women whose breast cancer comes back survive longer, U.S. researchers said on Tuesday. They said reducing stress during breast cancer treatment can keep the immune system strong and improve a woman's quality of life -- and these two factors help women live longer. They found women who took ...

Genes that make women more susceptible to breast cancer don't have any link to lifestyle factors that also raise their risk, a new study says. Some experts previously thought there might be dangerous interactions between breast cancer mutations and other risk factors for the disease, like taking hormone replacement therapy — and that these women had a particularly high risk ...

WASHINGTON (Reuters) - A U.S. advisory panel will meet in July to review two proposed new uses for Roche Holding AG's blockbuster cancer drug Avastin, the Food and Drug Administration said on Thursday. The committee of outside experts at a July 20 meeting will consider applications from Roche unit Genentech to promote Avastin for certain patients with advanced breast ...

WASHINGTON (Reuters) - Older women with early stage breast cancer can safely skip radiation therapy and go straight to taking pills that help keep tumors from coming back, researchers reported on Thursday. They said the finding, to be presented next month to a meeting of the American Society of Clinical Oncology, may save many women and their doctors a lot of ...

LONDON (Reuters) - British scientists have found five common genetic factors linked to the risk of developing breast cancer, giving researchers a better understanding of its causes and clues for developing more treatments. Douglas Easton from Britain's University of Cambridge led the largest genome-wide analysis of breast cancer patients to date, scanning the gene maps of 16,536 patients, and ...

NEW YORK (Reuters Health) - Whether breast cancer should be labeled as an occupational disease is still unclear, researchers behind a new study from China suggest. Breast cancer is the most common cancer in women worldwide, and so far only one country (Denmark) has awarded compensation to shift workers who develop the disease. If more were to follow suit, it could ...

WASHINGTON (Reuters) - U.S. regulators are investigating potential risks from Abbott Laboratories Inc's HIV drug Kaletra, GlaxoSmithKline Plc's prostate drug Avodart and other medicines. The Food and Drug Administration said on Monday it was probing reports of liver toxicity with patients who used Kaletra to prevent HIV infection after exposure to the AIDS virus. The agency also said ...